Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Colorectal Neoplasms

Free Subscription Articles published in Lancet Retrieve available abstracts of 26 articles: HTML format

Single Articles

October 2026
1. CIRACI P, Cremolini C
   Optimising late-line treatment administration in metastatic colorectal cancer: an even brighter SUNLIGHT.
   Lancet. 2026 Oct 24:S0140-6736(26)02034-9. doi: 10.1016/S0140-6736(26)02034.
   PubMed    
   
   
   
2. SAKAKIDA T, Taniguchi H, Asayama M, Suwa Y, et al
   14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.
   Lancet. 2026 Oct 24:S0140-6736(26)01782-4. doi: 10.1016/S0140-6736(26)01782.
   PubMed     Abstract available
   
   
   
3. CHALABI M, van den Dungen LDW, de Gooyer PGM, Balduzzi S, et al
   Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.
   Lancet. 2026 Oct 21:S0140-6736(26)01602-8. doi: 10.1016/S0140-6736(26)01602.
   PubMed     Abstract available
   
   
   
4. GILL S, Loree J
   Redefining curative treatment for early-stage mismatch repair-deficient colon cancer.
   Lancet. 2026 Oct 21:S0140-6736(26)01612-0. doi: 10.1016/S0140-6736(26)01612.
   PubMed    
   
   
   
5. LADABAUM U, Dominitz JA, Meester RGS, Robertson DJ, et al
   Colonoscopy screening and colorectal cancer outcomes: the NordICC trial.
   Lancet. 2026;408:1453.
   PubMed    
   
   
   
6. KAMINSKI MF, Kalager M, Regula J, Adami HO, et al
   Colonoscopy screening and colorectal cancer outcomes: the NordICC trial - Authors' reply.
   Lancet. 2026;408:1453-1454.
   PubMed    
   
   
   
7. BRENNER H, Carlsson SV, Hoffmeister M
   Colonoscopy screening and colorectal cancer outcomes: the NordICC trial.
   Lancet. 2026;408:1452-1453.
   PubMed    
   
   
   
8. MARTINS J, Bhangu A
   Colonoscopy screening and colorectal cancer outcomes: the NordICC trial.
   Lancet. 2026;408:1452.
   PubMed    
   
   
   May 2026
9. KAMINSKI MF, Kalager M, Loberg M, Emilsson L, et al
   Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial.
   Lancet. 2026;407:1787-1795.
   PubMed     Abstract available
   
   
   
10. OBAYEMI JE, Agbedinu K, Kwakye G
    Myopic medical harm: a man receives free colon cancer screening in Ghana.
    Lancet. 2026;407:1676-1677.
    PubMed    
    
    
    March 2026
11. CERCEK A, Wilson C, Xu RH
    Announcing the Lancet Commission on colorectal cancer: addressing the rising global burden.
    Lancet. 2026 Mar 26:S0140-6736(26)00418-6. doi: 10.1016/S0140-6736(26)00418.
    PubMed    
    
    
    November 2025
12. RASSCHAERT G, Tejpar S
    The dawn of immunotherapy in mismatch repair proficient colorectal cancer.
    Lancet. 2025;406:2302-2304.
    PubMed    
    
    
    October 2025
13. HECHT JR, Park YS, Tabernero J, Lee MA, et al
    Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
    Lancet. 2025 Oct 20:S0140-6736(25)02025-2. doi: 10.1016/S0140-6736(25)02025.
    PubMed     Abstract available
    
    
    July 2025
14. GARVEY G, Baykeda TA, Jahan S
    Early-onset colorectal cancer among Indigenous populations.
    Lancet. 2025;406:331.
    PubMed    
    
    
    June 2025
15. RAO S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, et al
    Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial.
    Lancet. 2025;405:2144-2152.
    PubMed     Abstract available
    
    
    March 2025
16. THE LANCET
    Colorectal cancer screening: FIT for purpose?
    Lancet. 2025;405:1027.
    PubMed    
    
    
    
17. ROBB KA, Young B, Murphy MK, Duklas P, et al
    Behavioural interventions to increase uptake of FIT colorectal screening in Scotland (TEMPO): a nationwide, eight-arm, factorial, randomised controlled trial.
    Lancet. 2025;405:1081-1092.
    PubMed     Abstract available
    
    
    
18. CASTELLS A, Quintero E, Bujanda L, Castan-Cameo S, et al
    Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial.
    Lancet. 2025 Mar 27:S0140-6736(25)00145-X. doi: 10.1016/S0140-6736(25)00145.
    PubMed     Abstract available
    
    
    
19. BRETTHAUER M, Kalager M
    First head-to-head trial of colonoscopy versus faecal testing for colorectal cancer screening.
    Lancet. 2025 Mar 27:S0140-6736(25)00288-0. doi: 10.1016/S0140-6736(25)00288.
    PubMed    
    
    
    January 2025
20. HALDAR SD, Kopetz S
    Dual checkpoint blockade for microsatellite instability-high colorectal cancer.
    Lancet. 2025 Jan 23:S0140-6736(25)00144-8. doi: 10.1016/S0140-6736(25)00144.
    PubMed    
    
    
    
21. ANDRE T, Elez E, Lenz HJ, Jensen LH, et al
    Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.
    Lancet. 2025 Jan 23:S0140-6736(24)02848-4. doi: 10.1016/S0140-6736(24)02848.
    PubMed     Abstract available
    
    
    September 2024
22. ADAM R, Piedvache C, Chiche L, Adam JP, et al
    Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial.
    Lancet. 2024;404:1107-1118.
    PubMed     Abstract available
    
    
    
23. HEINEMANN V, Stintzing S
    Liver transplantation in metastatic colorectal cancer: a new standard of care?
    Lancet. 2024;404:1078-1079.
    PubMed    
    
    
    July 2024
24. HOSTEN K, Kazi SI, Kardos A
    Takotsubo cardiomyopathy in a patient with Lynch syndrome.
    Lancet. 2024;404:276.
    PubMed    
    
    
    June 2024
25. ENG C, Yoshino T, Ruiz-Garcia E, Mostafa N, et al
    Colorectal cancer.
    Lancet. 2024 Jun 20:S0140-6736(24)00360-X. doi: 10.1016/S0140-6736(24)00360.
    PubMed     Abstract available
    
    
    May 2024
26. EDERHY S, Demondion P, Ali A, Montravers F, et al
    A right atrial mass and colonic cancer in a patient with Lynch syndrome.
    Lancet. 2024;403:e32.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum